Compare MRK & SCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRK | SCCO |
|---|---|---|
| Founded | 2000 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 155.9B |
| IPO Year | 1994 | 1996 |
| Metric | MRK | SCCO |
|---|---|---|
| Price | $119.53 | $192.09 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 17 | 11 |
| Target Price | $125.59 | ★ $138.93 |
| AVG Volume (30 Days) | ★ 6.6M | 1.6M |
| Earning Date | 04-30-2026 | 04-27-2026 |
| Dividend Yield | ★ 2.83% | 2.05% |
| EPS Growth | 8.01 | ★ 20.74 |
| EPS | ★ 7.28 | 5.24 |
| Revenue | ★ $65,011,000,000.00 | $6,654,500,000.00 |
| Revenue This Year | $3.73 | $16.76 |
| Revenue Next Year | $5.42 | N/A |
| P/E Ratio | ★ $16.46 | $37.00 |
| Revenue Growth | 1.31 | ★ 23.69 |
| 52 Week Low | $75.40 | $84.97 |
| 52 Week High | $125.14 | $223.89 |
| Indicator | MRK | SCCO |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 58.11 |
| Support Level | $116.50 | $180.57 |
| Resistance Level | $125.14 | $221.35 |
| Average True Range (ATR) | 2.56 | 6.82 |
| MACD | -0.05 | 3.65 |
| Stochastic Oscillator | 35.07 | 83.55 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.